465 related articles for article (PubMed ID: 17222790)
1. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
Pan Q; Chanthery Y; Liang WC; Stawicki S; Mak J; Rathore N; Tong RK; Kowalski J; Yee SF; Pacheco G; Ross S; Cheng Z; Le Couter J; Plowman G; Peale F; Koch AW; Wu Y; Bagri A; Tessier-Lavigne M; Watts RJ
Cancer Cell; 2007 Jan; 11(1):53-67. PubMed ID: 17222790
[TBL] [Abstract][Full Text] [Related]
2. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
Liang WC; Dennis MS; Stawicki S; Chanthery Y; Pan Q; Chen Y; Eigenbrot C; Yin J; Koch AW; Wu X; Ferrara N; Bagri A; Tessier-Lavigne M; Watts RJ; Wu Y
J Mol Biol; 2007 Feb; 366(3):815-29. PubMed ID: 17196977
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
Saban MR; Sferra TJ; Davis CA; Simpson C; Allen A; Maier J; Fowler B; Knowlton N; Birder L; Wu XR; Saban R
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1245-56. PubMed ID: 20861073
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 expression in cancer and development.
Jubb AM; Strickland LA; Liu SD; Mak J; Schmidt M; Koeppen H
J Pathol; 2012 Jan; 226(1):50-60. PubMed ID: 22025255
[TBL] [Abstract][Full Text] [Related]
5. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
Mazurek AM; Olbryt M
Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
Geretti E; Shimizu A; Klagsbrun M
Angiogenesis; 2008; 11(1):31-9. PubMed ID: 18283547
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
Miao HQ; Lee P; Lin H; Soker S; Klagsbrun M
FASEB J; 2000 Dec; 14(15):2532-9. PubMed ID: 11099472
[TBL] [Abstract][Full Text] [Related]
8. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.
Shintani Y; Takashima S; Asano Y; Kato H; Liao Y; Yamazaki S; Tsukamoto O; Seguchi O; Yamamoto H; Fukushima T; Sugahara K; Kitakaze M; Hori M
EMBO J; 2006 Jul; 25(13):3045-55. PubMed ID: 16763549
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.
Osada H; Tokunaga T; Nishi M; Hatanaka H; Abe Y; Tsugu A; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
Anticancer Res; 2004; 24(2B):547-52. PubMed ID: 15160992
[TBL] [Abstract][Full Text] [Related]
11. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
12. Neuropilins in neoplasms: expression, regulation, and function.
Bielenberg DR; Pettaway CA; Takashima S; Klagsbrun M
Exp Cell Res; 2006 Mar; 312(5):584-93. PubMed ID: 16445911
[TBL] [Abstract][Full Text] [Related]
13. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.
Hsieh SH; Ying NW; Wu MH; Chiang WF; Hsu CL; Wong TY; Jin YT; Hong TM; Chen YL
Oncogene; 2008 Jun; 27(26):3746-53. PubMed ID: 18223683
[TBL] [Abstract][Full Text] [Related]
15. Targeting endothelial and tumor cells with semaphorins.
Bielenberg DR; Klagsbrun M
Cancer Metastasis Rev; 2007 Dec; 26(3-4):421-31. PubMed ID: 17768598
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
19. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
Crawford Y; Kasman I; Yu L; Zhong C; Wu X; Modrusan Z; Kaminker J; Ferrara N
Cancer Cell; 2009 Jan; 15(1):21-34. PubMed ID: 19111878
[TBL] [Abstract][Full Text] [Related]
20. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.
Casazza A; Laoui D; Wenes M; Rizzolio S; Bassani N; Mambretti M; Deschoemaeker S; Van Ginderachter JA; Tamagnone L; Mazzone M
Cancer Cell; 2013 Dec; 24(6):695-709. PubMed ID: 24332039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
